Operator
Good afternoon, and welcome to the Polarean Imaging plc Investor Presentation. [Operator Instructions] Before we begin, I’d like to submit the following poll. I’d now like to hand you over to Christopher Von Jako, CEO. Good afternoon, sir.
Christopher Von Jako
CEO & Director
Thank you so much. I appreciate it. So hello. As mentioned, my name is Chris Von Jako. I’m the CEO of Polarean, and I’m joined today by our CFO, Chuck Osborne. So thank you for taking the time to be with us. I’ll begin with an overview and some additional context on the RNS we released this morning. And after that, I’ll walk through an updated presentation, both as a refresher for those familiar with Polarean and as an introduction for any new to the story. Finally, Chuck and I will take a number of questions at the end of the presentation.
So before I begin, just as a reminder, these are the normal disclaimers. We are revolutionizing pulmonary medicine with our FDA-approved Xenon MRI platform. It is the only noninvasive radiation-free technology that shows the full picture of lung function. So usage is growing across our leading academic centers, both in clinical as well as research. And as you may know, our technology is available for use on all 3 major MRI vendors. So that includes Philips, GE and Siemens.
Reimbursement is active, which is great for us, and clinical sites are billing and getting paid for Xenon MRI exams. In March, we announced a third revenue vertical in our pharma trial, which is in pharma trials, where we also signed our first multicenter trial, and we continue to build a
#Polarean #Imaging #plc #PLLWF #Earnings #Call #Transcript